Overview

A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

Status:
Enrolling by invitation
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.
Phase:
N/A
Details
Lead Sponsor:
Hospital for Children and Adolescents, Finland
Treatments:
Estrogens
Estrone
Estropipate
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate